www.alliancepharma.co.uk
Alliance Pharma plc is a United Kingdom-based pharmaceutical company. The Company is engaged in the development, marketing and distribution of pharmaceutical products. Its brands include Nu-Seals, Forceval, Hydromol, Deltacortril, Symmetrel, Syntocinon, Naseptin, Syntometrine, Synacthen and Slow-K.
Alliance Pharma acquires Quinoderm and Ceanel brands for £1.5 mln
Alliance Pharma (LON:APH) has expanded its product portfolio with the acquisition of two skin care brands.
This morning it revealed the deal to acquire the Quinoderm and Ceanel brands from Ferndale Pharmaceuticals Ltd for £1.5m in cash. Quinoderm is a treatment for acne and Ceanel is a shampoo treatment for scalp psoriasis.
The two brands contributed sales of £600,000 in the twelve months to September 30 2011.
"We are delighted to announce this acquisition, which extends our Dermatology portfolio. Quinoderm complements our existing product Rizuderm (isotretinoin), a treatment for severe acne acquired in September this year,” said chief executive John Dawson.
"Today's acquisition, which represents our third transaction this year, is expected to be earnings enhancing in 2012. We continue to evaluate further opportunities to broaden our product portfolio."
The deal is being funded via a £20 million revolving credit facility which was set up last November.
The facility was established to support the group’s acquisition strategy. Today it said that £6.5 million of the facility has now been used.


















